Cargando…
Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study
INTRODUCTION: Schizophrenia (SCZ) is one of the most severe mental disorders. Several elements involved in pathogenesis have been characterized recently. However, tools for diagnosis and risk prediction are limited. Elucidation of the underlying genomic and molecular mechanisms of SCA remains a chal...
Autores principales: | Naifar, M., Abdellah, T., Franklin, D., Carine, P., Plichet, T., Maalej, M., Guidara, W., Ayadi, F., Bekri, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405714/ http://dx.doi.org/10.1192/j.eurpsy.2023.963 |
Ejemplares similares
-
Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study
por: Naifar, M., et al.
Publicado: (2023) -
C-reactive protein levels and cognitive functions in patients with bipolar disorder
por: Elleuch, O., et al.
Publicado: (2023) -
Association between oxidative stress and altered cholesterol metabolism in patients with Bipolar Disorder
por: Guidara, W., et al.
Publicado: (2023) -
Evolution of some liver function markers after treatment in patients with schizophrenia and bipolar disorder
por: Sellami, S., et al.
Publicado: (2023) -
EEG power spectrum analysis for Tunisian schizophrenic patients
por: Mnif, M., et al.
Publicado: (2023)